Skip to content

{ Tag Archives } Launch

Sweaty Palms Causes

 
Sweaty palms, more correctly known as palmar hyperhidrosis, is often a issue that impacts about 1 percent of the U . s . people. Although the particular trigger of sweaty hands is also discussed, numerous professionals believe its due to a hyper sympathetic nerves, triggering the perspire glands in the arms to produce excessive sweating.
Sweat [...]

Bookmark and Share Also tagged , , , , , , , , , , , , , , , , , , , , ,

Innovative Therapies Inc. (ITI) Launches The ITI SensiSkin Drape For Sensitive Skin/Geriatric Patients

Innovative Therapies Inc. (ITI) announced the launch of its proprietary ITI SensiSkin Drape for Sensitive Skin. The latest in ITI’s innovative negative pressure wound therapy (NPWT) technologies, the SensiSkin Drape provides welcome relief for patients with fragile skin…

Bookmark and Share Also tagged , , , , , , ,

Hi-Tech Pharmacal’s ECR Subsidiary To Launch A New Dermatitis Treatment

Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced that it received clearance from the FDA to market Tropazone™ lotion, a prescription dermatological product which will be promoted by Hi-Tech’s branded marketing subsidiary, ECR Pharmaceuticals Co., Inc…

Bookmark and Share Also tagged , , , , , , , , , , , ,

Theravance And Astellas Announce The Commercial Launch Of VIBATIVTM (telavancin) In The United States

Theravance, Inc. (NASDAQ: THRX) and Astellas Pharma US, Inc. announced today the commercial launch of VIBATIV™ (telavancin) in the United States. On September 11, 2009, the U.S. Food and Drug Administration (FDA) approved VIBATIV for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus [...]

Bookmark and Share Also tagged , , , , , , , , , , , , , , , , , ,

Reveal Sciences Launches At-Home Skin Typing And Analysis Kit For Consumers

Reveal Sciences, LLC, a cosmetics and aesthetics innovation company pioneering breakthrough skin care diagnostics, has announced the launch of the new consumer At-Home Skin Typing and Analysis Kit. Developed by physician Damon Borich, M.D., CEO of Reveal Sciences, and his scientific team, the novel skincare analysis technology is the next-generation spin-off from the company’s professional [...]

Bookmark and Share Also tagged , , , , , , , , , , , , , , , ,

Onset Therapeutics Launches HYLATOPIC™ Emollient Foam For Atopic Dermatitis

Onset Therapeutics, a specialty pharmaceutical company focused in dermatology, announced the FDA approval and commercial launch of HYLATOPIC™ Emollient Foam, a unique, non-steroidal prescription product indicated to manage and relieve the burning, itching and pain experienced with various types of dermatoses, including atopic dermatitis, allergic contact dermatitis and radiation dermatitis.

Bookmark and Share Also tagged , , , , , , , , , ,

Innovative Treatment Approach Offers New Hope For Eczema Sufferers With Moderate To Severe Disease

The British Association of Dermatology annual meeting sees the launch of the first topical calcineurin inhibitor to be approved for the maintenance treatment of moderate to severe atopic eczema to prevent flares and prolong flare-free intervals. PROTOPIC ointment (tacrolimus monohydrate) is already licensed to treat moderate and severe eczema (atopic dermatitis), often involving the [...]

Bookmark and Share Also tagged , , , , , , , , , , , , , , ,

Innovative Treatment Approach Offers New Hope For Eczema Sufferers With Moderate To Severe Disease PROTOPIC Ointment Can Help Prevent Eczema Flares

Today sees the European launch of the first topical calcineurin inhibitor to be approved for the maintenance treatment of eczema to prevent flares and prolong flare-free intervals. PROTOPIC ointment (tacrolimus monohydrate) is already licensed to treat moderate and severe eczema (atopic dermatitis), often involving the treatment of flares as and when they occur.

Bookmark and Share Also tagged , , , , , , , , , , , , , ,

Innovative Treatment Approach Offers New Hope For Eczema Sufferers With Moderate To Severe Disease

Today sees the European launch of the first topical calcineurin inhibitor to be approved for the maintenance treatment of eczema to prevent flares and prolong flare-free intervals. PROTOPIC ointment (tacrolimus monohydrate) is already licensed to treat moderate and severe eczema (atopic dermatitis), often involving the treatment of flares as and when they occur.

Bookmark and Share Also tagged , , , , , , , , , , , , , ,

Sun Awareness Week – Survey Results Released

Pale skinned people who are most at risk of skin cancer are ignoring sun safety advice, according to research released today to launch Sun Awareness Week 2009. The survey of 1500 UK adults looked at people’s behaviour in the sun in relation to their individual risk of skin cancer, as well [...]

Bookmark and Share Also tagged , , , , , , , , ,